Current Role of CT Imaging in Assessing Pulmonary Diseases

Abstract

CT imaging provides both high spatial resolution and detailed views of lung components which makes it essential for diagnosing and monitoring pulmonary diseases. This research examines the part of Computed Tomography imaging in indentification and treatment of pulmonary diseases such as carcinoma, pneumonia, pulmonary fibrosis and chronic obstructive pulmonary disease. This review examines CT imaging diagnostic precision in various pulmonary diseases particularly when using High-Resolution Computed Tomography for fibrosis and emphysema evaluation and Low-Dose CT for early-stage lung carcinoma detection. The diagnostic accuracy and safety of CT imaging have improved through technological developments including Multi-detector Computed tomography and iterative reconstruction techniques which also reduce patient radiation exposure. CT imaging serves as an important tool for managing chronic lung diseases because it helps monitor disease progression and evaluate treatment effectiveness. The benefits of CT imaging exist alongside three major challenges which include radiation exposure and the risk of overdiagnosis together with the need for better functional imaging capabilities. Future research should prioritize methods to decrease radiation exposure and enhance disease tracking abilities of CT while integrating artificial intelligence technology to boost diagnostic precision.  Computed Tomography imaging plays a vital role in pulmonary disease diagnosis and treatment as it continues to grow through ongoing developments in clinical practice.